IL10 is a powerful TH-2 cell cytokine produced by lymphoid cells that limit
s HIV-1 replication in vivo, ostensibly by inhibiting macrophage/monocyte a
nd T-cell lymphocyte replication and secretion of inflammatory cytokines (I
L1, TNF alpha, IL6, IL8, and IL12). A genetic epidemiological scan of patie
nts enrolled in AIDS cohorts for candidate gene-linked short tandem repeat
polymorphisms revealed significant genotype associations for HIV-1 infectio
n and progression to AIDS with markers adjacent to and tracking (by linkage
disequilibrium) common single nucleotide polymorphic variants in the IL10
promoter region. Individuals carrying the IL10-5'-592A (IL10-5'A) promoter
allele possibly were at increased risk for HIV-1 infection, and once infect
ed they progressed to AIDS more rapidly than homozygotes for the alternativ
e IL10-5'-592 C/C (IL10-+/+) genotype. particularly in the later stages of
HIV-1 infection. An estimated 25-30% of long-term nonprogressors (who avoid
clinical AIDS for 10 or more years after HIV-1 infection) can be attribute
d to their IL10-+/+ promoter genotype. Alternative IL10 promoter alleles ar
e functionally distinct in relative IL10 production, in retention of an avi
an erythroblastosis virus transcription factor recognition sequence and in
binding to specific putative nuclear transcription factors, suggesting a po
tential mechanism whereby IL10-5'A down-regulation of inhibitory IL10 facil
itates HIV-1 replication in vivo, accelerating the onset of AIDS.